05.28.25 -- Evolve Or Fade Away? Biotech's Outsourcing Moment In Trump's Tariff Tangle

Subcutaneous (Sub-Q) delivery offers self-administration and fewer hospital visits but is challenging for high-dose biologics. Nanoform developed a concentrated, non-aqueous Sub-Q IgG1 suspension using its patented dry particle platform. The study evaluated particle size impact, formulation properties, protein quality, and stability, with pharmacokinetic studies ongoing. Key topics include Sub-Q benefits, Nanoform’s dry particle process, and non-aqueous suspension formulation. Click here to learn more.

Here, industry experts explore some of the key challenges in HPAPI drug product manufacturing and highlight essential factors sponsors should consider when evaluating a CDMO partner.

Review five key factors driving seamless and efficient technology transfer, and how a culture of technical expertise, customer focus, and operational flexibility is crucial to CDMO success.

Explore the challenges to effective delivery of drugs to the eye, intricacies of ophthalmic drug delivery, and advantages of nanoparticles as an enabling technology for ocular drug-delivery systems.

In this Outsourced Pharma Live digital event, participants explored the critical role CDMOs played in achieving and maintaining CMC compliance across the drug development lifecycle. The session highlighted how to leverage CDMO expertise, offering viewers practical insights on aligning CMC compliance strategies with CDMO capabilities to support successful drug launches.

Uncover the unique challenges faced in the formulation development of ocular therapies and how they can be overcome to ensure safe, efficient, and targeted treatments for patients.

Ensure the success of your spray-dried powder formulations by thoroughly assessing their physical properties early in the development process to optimize handling, stability, and performance.

As peptide therapeutics establish themselves as a leading technology for treating chronic indications, drug sponsors must identify reliable peptide building block suppliers to secure high-quality materials.

This paper explores the importance of sample prep optimization and the application of liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) in bioanalytical development.

Lonza's Route Scouting Service empowers biotech partners to overcome the complexities of API development and bring life-changing medicines to market faster.

Our innovative business model doesn't add additional costs to your project. Review our regulatory starting material capabilities and contact us to simplify your outsourcing solutions.